- Scheme Category:
- Equity Scheme >
- Sectoral/Thematic Funds
NAV: ₹ ↓ -0.06%
NAV chart
SMA (Simple Moving Average)
- 50 SMA
- 100 SMA
- 200 SMA
- 400 SMA
Returns
CAGR returns till date
CAGR returns of Nippon India Pharma Fund-Growth Plan-Growth Option and its peers as on 30 April, 2026| Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
|---|---|---|---|---|---|---|---|---|---|---|
| Nippon India Pharma Fund-Growth Plan-Growth Option | 1.55% | -0.06% | 0.8% | 5.58% | 6.09% | 4.04% | 22.17% | 13.34% | 18.9% | 14.45% |
| SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH | 4.34% | 0.23% | 1.46% | 5.71% | 8.21% | 4.56% | 24.91% | 15.57% | 20.11% | 12.33% |
| SBI ESG Exclusionary Strategy Fund - Regular Plan - Growth | -6.52% | -0.85% | -1.82% | 9.73% | -3.47% | 0.77% | 12.26% | 11.31% | 11.77% | 12.07% |
| SBI INFRASTRUCTURE FUND - REGULAR PLAN - GROWTH | 2.05% | -0.72% | 0.54% | 16.66% | 6.07% | 6.18% | 21.02% | 21.19% | 18.87% | 16.1% |
| SBI PSU Fund - REGULAR PLAN -Growth | 5.55% | -1.29% | -1.52% | 9.81% | 2.78% | 16.42% | 30.87% | 26.93% | 19.71% | 15.56% |
| SBI CONSUMPTION OPPORTUNITIES FUND - REGULAR - GROWTH | -5.46% | -0.83% | -1.06% | 10.77% | 1.03% | -4.44% | 11.24% | 15.49% | 13.84% | 14.51% |
Discrete returns (yearly)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | -10.27% | 7.14% | 3.79% | 2.14% | 67.04% | 22.66% | -10% | 40.12% | 34.25% | -3.81% |
Discrete returns (monthly)
| Month | Jul 2025 | Aug 2025 | Sep 2025 | Oct 2025 | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 | Mar 2026 | Apr 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | 2.59% | -1.48% | -2.59% | 2.16% | 0.82% | -1.31% | -4.73% | 5.23% | -4.93% | 5.96% |
Returns from spefic dates
| Description | CAGR returns from 18 Oct 2021 (Nifty 50 2021 high) | CAGR returns from 26 Sep 2024 (Nifty 50 2024 high) |
|---|---|---|
| Returns | 11.93% | -0.48% |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|---|---|---|---|
| 99.45% | 0.00% (Arbitrage: 0.00%) | 0.00% | 0.00% | 0.55% |
Equity
| Name | Symbol / ISIN | Sector | Weight % |
|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA (INE044A01036) | Pharmaceuticals & Biotechnology | 13.92% |
| Lupin Limited | LUPIN (INE326A01037) | Pharmaceuticals & Biotechnology | 8.45% |
| Divi's Laboratories Limited | DIVISLAB (INE361B01024) | Pharmaceuticals & Biotechnology | 6.41% |
| Dr. Reddy's Laboratories Limited | DRREDDY (INE089A01031) | Pharmaceuticals & Biotechnology | 5.96% |
| Cipla Limited | CIPLA (INE059A01026) | Pharmaceuticals & Biotechnology | 5.42% |
| Apollo Hospitals Enterprise Limited | APOLLOHOSP (INE437A01024) | Healthcare Services | 5.15% |
| MedPlus Health Services Limited | MEDPLUS (INE804L01022) | Retailing | 3.86% |
| Ajanta Pharma Limited | AJANTPHARM (INE031B01049) | Pharmaceuticals & Biotechnology | 3.36% |
| Max Healthcare Institute Limited | MAXHEALTH (INE027H01010) | Healthcare Services | 3.24% |
| Vijaya Diagnostic Centre Limited | VIJAYA (INE043W01024) | Healthcare Services | 3.15% |
| Sai Life Sciences Limited | SAILIFE (INE570L01029) | Pharmaceuticals & Biotechnology | 3.15% |
| Mankind Pharma Limited | MANKIND (INE634S01028) | Pharmaceuticals & Biotechnology | 2.87% |
| Aurobindo Pharma Limited | AUROPHARMA (INE406A01037) | Pharmaceuticals & Biotechnology | 2.81% |
| IPCA Laboratories Limited | IPCALAB (INE571A01038) | Pharmaceuticals & Biotechnology | 2.77% |
| GlaxoSmithKline Pharmaceuticals Limited | GLAXO (INE159A01016) | Pharmaceuticals & Biotechnology | 2.64% |
| Abbott India Limited | ABBOTINDIA (INE358A01014) | Pharmaceuticals & Biotechnology | 2.43% |
| Alkem Laboratories Limited | ALKEM (INE540L01014) | Pharmaceuticals & Biotechnology | 2.17% |
| JB Chemicals & Pharmaceuticals Limited | JBCHEPHARM (INE572A01036) | Pharmaceuticals & Biotechnology | 2.09% |
| Dr. Lal Path Labs Limited | LALPATHLAB (INE600L01024) | Healthcare Services | 2.02% |
| Thyrocare Technologies Limited | THYROCARE (INE594H01019) | Healthcare Services | 1.94% |
| Pfizer Limited | PFIZER (INE182A01018) | Pharmaceuticals & Biotechnology | 1.90% |
| Gland Pharma Limited | GLAND (INE068V01023) | Pharmaceuticals & Biotechnology | 1.72% |
| Narayana Hrudayalaya Limited | NH (INE410P01011) | Healthcare Services | 1.67% |
| Emcure Pharmaceuticals Limited | EMCURE (INE168P01015) | Pharmaceuticals & Biotechnology | 1.51% |
| Sanofi Consumer Healthcare India Limited | SANOFICONR (INE0UOS01011) | Pharmaceuticals & Biotechnology | 1.16% |
| Suraksha Diagnostic Limited | SURAKSHA (INE877V01027) | Healthcare Services | 1.12% |
| Fortis Healthcare Limited | FORTIS (INE061F01013) | Healthcare Services | 1.11% |
| Sanofi India Limited | SANOFI (INE058A01010) | Pharmaceuticals & Biotechnology | 0.94% |
| Syngene International Limited | SYNGENE (INE398R01022) | Healthcare Services | 0.93% |
| Akums Drugs and Pharmaceuticals Limited | AKUMS (INE09XN01023) | Pharmaceuticals & Biotechnology | 0.89% |
| Anthem Biosciences Limited | ANTHEM (INE0CZ201020) | Pharmaceuticals & Biotechnology | 0.88% |
| Biocon Limited | BIOCON (INE376G01013) | Pharmaceuticals & Biotechnology | 0.67% |
| AstraZeneca Pharma India Limited | ASTRAZEN (INE203A01020) | Pharmaceuticals & Biotechnology | 0.62% |
| Indoco Remedies Limited | INDOCO (INE873D01024) | Pharmaceuticals & Biotechnology | 0.38% |
| Concord Biotech Limited | CONCORDBIO (INE338H01029) | Pharmaceuticals & Biotechnology | 0.14% |
Portfolio data is as on date 31 March, 2026
NAV history
Nippon India Pharma Fund-Growth Plan-Growth Option - 30 days NAV (Net asset value) history
| Date | NAV | % change |
|---|---|---|
| 30 April, 2026 | 517.0628 | -0.06% |
| 29 April, 2026 | 517.3505 | 0.29% |
| 28 April, 2026 | 515.8532 | -0.36% |
| 27 April, 2026 | 517.7050 | 2.1% |
| 24 April, 2026 | 507.0446 | -1.15% |
| 23 April, 2026 | 512.9569 | 1.38% |
| 22 April, 2026 | 505.9512 | 0.34% |
| 21 April, 2026 | 504.2200 | 0.18% |
| 20 April, 2026 | 503.3006 | -0.28% |
| 17 April, 2026 | 504.6902 | 0.32% |
| 16 April, 2026 | 503.0968 | -0.14% |
| 15 April, 2026 | 503.7948 | 1.41% |
| 13 April, 2026 | 496.8099 | -0.13% |
| 10 April, 2026 | 497.4731 | 0.65% |
| 9 April, 2026 | 494.2580 | 0.67% |
| 8 April, 2026 | 490.9609 | 0.79% |
| 7 April, 2026 | 487.1131 | 0.24% |
| 6 April, 2026 | 485.9675 | 0.14% |
| 2 April, 2026 | 485.2674 | -0.56% |
| 1 April, 2026 | 487.9990 | -0.35% |
| 31 March, 2026 | 489.7116 | 0% |
| 30 March, 2026 | 489.7353 | -1.18% |
| 27 March, 2026 | 495.6005 | -0.94% |
| 25 March, 2026 | 500.3119 | 1.57% |
| 24 March, 2026 | 492.5647 | 1.16% |
| 23 March, 2026 | 486.9288 | -2.03% |
| 20 March, 2026 | 497.0102 | 1.12% |
| 19 March, 2026 | 491.5207 | -2.26% |
| 18 March, 2026 | 502.8705 | 0.54% |
| 17 March, 2026 | 500.1613 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of Nippon India Pharma Fund-Growth Plan-Growth Option?
The latest NAV of Nippon India Pharma Fund-Growth Plan-Growth Option is 517.0628 as on 30 April, 2026.What are YTD (year to date) returns of Nippon India Pharma Fund-Growth Plan-Growth Option?
The YTD (year to date) returns of Nippon India Pharma Fund-Growth Plan-Growth Option are 1.55% as on 30 April, 2026.What are 1 year returns of Nippon India Pharma Fund-Growth Plan-Growth Option?
The 1 year returns of Nippon India Pharma Fund-Growth Plan-Growth Option are 4.04% as on 30 April, 2026.What are 3 year CAGR returns of Nippon India Pharma Fund-Growth Plan-Growth Option?
The 3 year annualized returns (CAGR) of Nippon India Pharma Fund-Growth Plan-Growth Option are 22.17% as on 30 April, 2026.What are 5 year CAGR returns of Nippon India Pharma Fund-Growth Plan-Growth Option?
The 5 year annualized returns (CAGR) of Nippon India Pharma Fund-Growth Plan-Growth Option are 13.34% as on 30 April, 2026.What are 10 year CAGR returns of Nippon India Pharma Fund-Growth Plan-Growth Option?
The 10 year annualized returns (CAGR) of Nippon India Pharma Fund-Growth Plan-Growth Option are 13.34% as on 30 April, 2026.